Dr. Oliver Wehmeier

Dr. Oliver Wehmeier did his PhD in cancer research at the Leibniz Institute for Experimental Virology in 2000 and founded his first company the same year. CCS Cell Culture Service offered cell line generation and cell banking for pharma drug discovery and was the first supplier of custom assay ready cell banks in Europe initially used in High-Throughput-Screening campaigns. In 2012, CCS was successfully sold to a major CRO and Oliver was engaged in business development at different companies for two years before he started his new venture acCELLerate in 2014. At acCELLerate now the accumulated expertise in assay ready cells is transferred to applications in toxicology and GMP bioassays. Oliver is founder and manager of multiple life science companies in Europe and the USA.